Fundraising FoxCessation Therapeutics
San Jose, US · Founded 2022 · Delaware corporation
Find your way into Cessation Therapeutics
227 people in our graph can introduce you to the Cessation Therapeutics team.
Sign up to see every warm intro you have to Cessation Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cessation Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cessation Therapeutics develops immunotherapies, including monoclonal antibodies and vaccines, to treat substance use disorders and counter the effects of opioids such as fentanyl and heroin. The company works on medications aimed at preventing opioid overdose deaths.
Founders & leadership
Cessation Therapeutics was founded in 2022 by John D. Harkey, Jr..
JD
John D. Harkey, Jr.Co-Founder & Board Member
PB
Paul BremerResearch and Development DirectorPaul Bremer is Research and Development Director at Cessation Therapeutics, where he works on immunotherapies including monoclonal antibodies and vaccines for substance use disorders. He specializes in designing and synthesizing bioactive small molecules and protein conjugates for therapeutic applications.
AB
Andrew BarrettBoard Member, former Chief Scientific Officer
JS
Jay ShepardNamed on SEC filing
MP
Mark PearsonCo-Founder & Board Member
JH
John HarkeyNamed on SEC filing
DG
David GenecovCo-Founder, Former Chief Medical Officer & Board Member
ER
Eric RasmussenNamed on SEC filing
JK
John KatsilometesController
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 2 rounds · 2022–2024
▶$1MraisedApr 2024 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BarrettExecutive Officer
- Sharon TetlowDirector
- John HarkeyDirector
- Daniel FineDirector
- Jay ShepardDirector
- Mark PearsonDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5.8MraisedMay 2022 · 31 investors · BiotechnologyRule 506(c)
▶$5.8MraisedMay 2022 · 31 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Jay ShepardDirector
- Mark PearsonExecutive Officer, Director
- John HarkeyExecutive Officer, Director
- David GenecovDirector
- Eric RasmussenExecutive Officer
- Offering amount
- $10M
- Amount sold
- $5.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies working in the same space as Cessation Therapeutics.
Frequently asked questions
- What does Cessation Therapeutics do?
- Cessation Therapeutics develops immunotherapies, including monoclonal antibodies and vaccines, to treat substance use disorders and counter the effects of opioids such as fentanyl and heroin. The company works on medications aimed at preventing opioid overdose deaths.
- Who founded Cessation Therapeutics?
- Cessation Therapeutics was founded by John D. Harkey, Jr. in 2022.
- How much funding has Cessation Therapeutics raised?
- Cessation Therapeutics has disclosed $6.8M raised across 2 rounds.
- Where is Cessation Therapeutics headquartered?
- Cessation Therapeutics is headquartered in San Jose, US.